Literature DB >> 7628842

Spectrum of vascular pathology affecting patients with the antiphospholipid syndrome.

M D Hughson1, G A McCarty, R A Brumback.   

Abstract

A thrombotic microangiopathy that is identified in patients with the antiphospholipid syndrome (APS) represents only a part of the vascular pathology that can be associated with antiphospholipid antibodies (aPL). Tissues from two autopsies, four renal biopsies, two skin biopsies, and one amputated leg were obtained from six patients who met criteria for the diagnosis of APS. Three patients had systemic lupus erythematosus (SLE), one had lupus-like disease, and two had a primary APS. Five of the patients were hypertensive. Arteries of three patients disclosed fibrin thrombi along with widespread obstruction by recanalized intimal connective tissue. Small renal, leptomeningeal, and pulmonary arteries showed concentric cellular and fibrous intimal hyperplasia indistinguishable from hypertensive vascular disease. Glomerular capillary and afferent arteriolar thrombi were found in renal biopsies from two SLE patients. One of these SLE patients required a leg amputation in which the popliteal artery demonstrated thrombosis, intimal hyperplasia, and acute inflammation. The findings support clinical and experimental data that indicate aPLs cause thrombosis but suggest diversity in the pathogenetic mechanisms aPLs are capable of promoting. Inflammation seems to be rare and to accompany thrombosis. Intimal hyperplasia is particularly common. Its involvement of renal arteries may contribute to hypertension that develops in some APS patients.

Entities:  

Mesh:

Year:  1995        PMID: 7628842     DOI: 10.1016/0046-8177(95)90218-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

Review 1.  Renal involvement in antiphospholipid syndrome.

Authors:  Francisco Vileimar Andrade de Azevedo; Diego Germano Maia; Jozelio Freire de Carvalho; Carlos Ewerton Maia Rodrigues
Journal:  Rheumatol Int       Date:  2018-05-05       Impact factor: 2.631

Review 2.  [Antiphospholipid syndrome].

Authors:  C Specker
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

3.  [Antiphospholipid syndrome].

Authors:  C Specker
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

4.  [Antiphospholipid syndrome].

Authors:  C Specker
Journal:  Z Rheumatol       Date:  2007-02       Impact factor: 1.372

5.  Primary antiphospholipid antibody syndrome: neuroradiologic findings in 11 patients.

Authors:  J H Kim; C G Choi; S J Choi; H K Lee; D C Suh
Journal:  Korean J Radiol       Date:  2000 Jan-Mar       Impact factor: 3.500

Review 6.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

7.  Catastrophic antiphospholipid syndrome in a 14-year-old child.

Authors:  George Tsirpanlis; George Moustakas; Eleni Sakka; George Triantafyllis; Flora Sotsiou; Helen Liapis; Panos Ziroyannis
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.651

Review 8.  Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis.

Authors:  M C Amigo; R García-Torres
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.686

9.  Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension.

Authors:  Jina Yeo; Nami Shin; Kyung-Jin Ahn; Miryoung Seo; Albert Youngwoo Jang; Minsu Kim; Wook-Jin Chung
Journal:  Clin Hypertens       Date:  2022-04-01

Review 10.  Interstitial lung diseases-can pathologists arrive at an etiology-based diagnosis? A critical update.

Authors:  Helmut H Popper
Journal:  Virchows Arch       Date:  2012-12-07       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.